Canary Capital Brings Injective to Nasdaq With New INJ Staked ETF

Canary Capital has launched an exchange-traded fund for Injective’s INJ token, allowing investors to gain exposure to the cryptocurrency and earn potential staking rewards. Digital asset investment management firm Canary Capital has launched an exchange-traded fund (ETF) based on Injective (INJ), providing investors exposure to the cryptocurrency through traditional brokerage accounts. In addition, the product offers potential returns from blockchain staking rewards . The firm’s CEO, Steven McClurg, said the launch expands Canary Capital’s digital asset investment offerings, which include the Canary XRP ETF and Canary HBAR ETF. It also reflects growing institutional interest in cryptocurrency products that combine price exposure with staking rewards.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to Bitcoin.com News.